215 related articles for article (PubMed ID: 22732476)
21. Pharmacokinetics, biodistribution, and radioimmunotherapy with monoclonal antibody 776.1 in a murine model of human ovarian cancer.
Berger MA; Masters GR; Singleton J; Scully MS; Grimm LG; Soltis DA; Albone EF
Cancer Biother Radiopharm; 2005 Dec; 20(6):589-602. PubMed ID: 16398611
[TBL] [Abstract][Full Text] [Related]
22. Imaging and phase I study of 111In- and 90Y-labeled anti-LewisY monoclonal antibody B3.
Pai-Scherf LH; Carrasquillo JA; Paik C; Gansow O; Whatley M; Pearson D; Webber K; Hamilton M; Allegra C; Brechbiel M; Willingham MC; Pastan I
Clin Cancer Res; 2000 May; 6(5):1720-30. PubMed ID: 10815890
[TBL] [Abstract][Full Text] [Related]
23. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
Griffiths GL; Govindan SV; Sharkey RM; Fisher DR; Goldenberg DM
J Nucl Med; 2003 Jan; 44(1):77-84. PubMed ID: 12515879
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4.
Gold DV; Cardillo T; Vardi Y; Blumenthal R
Int J Cancer; 1997 May; 71(4):660-7. PubMed ID: 9178823
[TBL] [Abstract][Full Text] [Related]
25. Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects.
Chakraborty M; Gelbard A; Carrasquillo JA; Yu S; Mamede M; Paik CH; Camphausen K; Schlom J; Hodge JW
Cancer Immunol Immunother; 2008 Aug; 57(8):1173-83. PubMed ID: 18256832
[TBL] [Abstract][Full Text] [Related]
26. The treatment of patients with recurrent malignant gliomas with intratumoral radioimmunoconjugates.
Hopkins K; Papanastassiou V; Kemshead JT
Recent Results Cancer Res; 1996; 141():159-75. PubMed ID: 8722426
[No Abstract] [Full Text] [Related]
27. Optimization of 90 Y-antiCD20 preparation for radioimmunotherapy.
Gholipour N; Vakili A; Radfar E; Jalilian AR; Bahrami-Samani A; Shirvani-Arani S; Ghannadi-Maragheh M
J Cancer Res Ther; 2013; 9(2):199-204. PubMed ID: 23771358
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer.
Cardillo TM; Ying Z; Gold DV
Clin Cancer Res; 2001 Oct; 7(10):3186-92. PubMed ID: 11595713
[TBL] [Abstract][Full Text] [Related]
29. [Radioimmunotherapy with (90)Y-ibritumomab tiuxetan (Zevalin). Spanish Nuclear Medicine Society].
Bello P; Almoguera MI; Pajares M; Olivas C; Lapeña L; Freire JM;
Rev Esp Med Nucl; 2010; 29(1):50-2. PubMed ID: 19963305
[No Abstract] [Full Text] [Related]
30. Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
Ma D; McDevitt MR; Barendswaard E; Lai L; Curcio MJ; Pellegrini V; Brechbiel MW; Scheinberg DA
Leukemia; 2002 Jan; 16(1):60-6. PubMed ID: 11840264
[TBL] [Abstract][Full Text] [Related]
31. Preclinical Characterization of the Radioimmunoconjugate
Funase Y; Nakamura E; Kajita M; Saito Y; Oshikiri S; Kitano M; Tokura M; Hino A; Uehara T
J Nucl Med; 2021 Feb; 62(2):232-239. PubMed ID: 32737245
[TBL] [Abstract][Full Text] [Related]
32. Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity.
Hanaoka H; Katagiri T; Fukukawa C; Yoshioka H; Yamamoto S; Iida Y; Higuchi T; Oriuchi N; Paudyal B; Paudyal P; Nakamura Y; Endo K
Ann Nucl Med; 2009 Jul; 23(5):479-85. PubMed ID: 19412654
[TBL] [Abstract][Full Text] [Related]
33. Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): studies in nude mice.
Vallabhajosula S; Smith-Jones PM; Navarro V; Goldsmith SJ; Bander NH
Prostate; 2004 Feb; 58(2):145-55. PubMed ID: 14716739
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic efficacy evaluation of radioimmunotherapy with
Sudo H; Tsuji AB; Sugyo A; Saga T; Kaneko MK; Kato Y; Higashi T
Cancer Sci; 2019 May; 110(5):1653-1664. PubMed ID: 30801908
[TBL] [Abstract][Full Text] [Related]
35. Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase.
Yudistiro R; Hanaoka H; Katsumata N; Yamaguchi A; Tsushima Y
Mol Pharm; 2018 Jun; 15(6):2165-2173. PubMed ID: 29733658
[TBL] [Abstract][Full Text] [Related]
36. Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5.
Tsai SW; Sun Y; Williams LE; Raubitschek AA; Wu AM; Shively JE
Bioconjug Chem; 2000; 11(3):327-34. PubMed ID: 10821648
[TBL] [Abstract][Full Text] [Related]
37. Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2.
Yamamoto A; Sawada T; Yamashita Y; Nishihara T; Ho JJ; Kim Y; Chung KH
Oncol Rep; 1999; 6(1):179-84. PubMed ID: 9864424
[TBL] [Abstract][Full Text] [Related]
38. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
[TBL] [Abstract][Full Text] [Related]
39. Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation.
Dahle J; Bruland OS; Larsen RH
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):186-92. PubMed ID: 18722269
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]